Reduced insulin clearance has been demonstrated in experimental models of insulin resistance ([@B1]) and conditions associated with insulin resistance ([@B2]--[@B5]). Insulin clearance partially explains the variability of fasting insulin independently of the effect of insulin resistance, insulin secretion, adiposity, and plasma glucose ([@B6]). In response to their higher insulin resistance, minority populations have lower insulin clearance than non-Hispanic whites ([@B4],[@B5],[@B7]). In these studies, however, results were not adjusted for insulin resistance. Therefore, we aimed to examine insulin clearance across sex, race/ethnicity populations, and varying states of glucose tolerance in the Insulin Resistance Atherosclerosis Study (IRAS) ([@B8]).

RESEARCH DESIGN AND METHODS {#s1}
===========================

The design and methods of the IRAS have previously been described in detail ([@B8]). The present report includes information on 1,295 participants, none of whom were treated with glucose-lowering medications.

Insulin sensitivity, insulin secretion, and insulin clearance were measured by the frequently sampled intravenous glucose tolerance test. Insulin sensitivity, expressed as the insulin sensitivity index (*S*~I~), was calculated using mathematical modeling methods (MINMOD version 3.0 \[1994\]; Harms Software, Los Angeles, CA). Acute insulin secretion (AIR) was calculated as the mean of 2- and 4-min insulin concentrations after glucose administration. MCRI was calculated as the ratio of the insulin dose over the incremental area under the curve of insulin from 20 min to infinity ([@B9]).

Statistical analyses were performed using the SAS statistical software (version 9.2; SAS Institute, Cary, NC). Means ± SE or proportions (95% CI) were calculated by one-way ANCOVA or logistic regression to account for the effect of covariates (age, sex, race/ethnicity, and clinic). Pearson correlation analysis was used to examine the relationship of MCRI with *S*~I~, AIR, fasting insulin, and waist circumference. Independent relationships of relevant variables with MCRI were established using the GENMOD procedure to account for the effect of categorical and standardized continuous variables. Log-transformed values of age, insulin, *S*~I~, AIR, and MCRI were used to meet statistical assumptions.

RESULTS {#s2}
=======

MCRI was not related to age and sex ([Table 1](#T1){ref-type="table"}). Minority populations and family history of diabetes were associated with lower MCRI. MCRI was directly related to *S*~I~ and inversely to adiposity, plasma glucose, fasting insulin, and AIR. Compared with impaired glucose tolerance, MCRI was higher in normal glucose tolerance (5.64 ± 0.10 vs. 4.53 ± 0.12 mL/kg/min, *P* \< 0.001) and lower in diabetes (3.94 ± 0.11 mL/kg/min, *P* \< 0.001).
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MCRI correlated directly with *S*~I~ in both nondiabetic (*r* = 0.77) and diabetic (*r* = 0.58) individuals and inversely with fasting insulin (*r* = −0.69 and −0.64, respectively), waist circumference (*r* = −0.56 and −0.46), AIR (*r* = −0.47 and −0.61) ([Supplementary Fig. 1](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-0101/-/DC1)).

The relation of race/ethnicity, family history of diabetes, and glucose tolerance to MCRI was no longer statistically significant after adjustment for BMI, waist circumference, *S*~I~, and AIR ([Supplementary Table 1](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-0101/-/DC1)). BMI (β −7.2 ± 1.7, *P* \< 0.001), waist circumference (β −3.9 ± 1.8, *P* \< 0.05), *S*~I~ (β 27.4 ± 1.1, *P* \< 0.001), and AIR (β −12.5 ± 0.9, *P* \< 0.001) were independently related to MCRI. The relation of BMI, *S*~I~, and AIR to MCRI was consistent across sex, race/ethnicity populations, and varying states of glucose tolerance, adiposity, and family history of diabetes ([Supplementary Table 2](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-0101/-/DC1)).

CONCLUSIONS {#s3}
===========

Our study has several novel findings: *1*) insulin clearance is not associated with age or sex; *2*) insulin sensitivity, insulin secretion, and adiposity are independently related to insulin clearance across sex, race/ethnic populations, varying states of glucose tolerance and adiposity, and family history of diabetes; and *3*) insulin sensitivity, insulin secretion, and adiposity appear to explain differences in insulin clearance by race/ethnicity and glucose tolerance status.

In the fasting state, the liver clears \~40--60% of the insulin concentration in the portal blood ([@B10]). Results from a study of intentional weight gain in men with normal weight (change in BMI from 21.8 to 23.8 kg/m^2^ in 15 weeks) suggest that reduced insulin clearance may be the most important compensatory mechanism for explaining the increase in basal and stimulated insulin concentrations ([@B11]). Insulin clearance has also been described as the first compensatory mechanism to experimental fat-induced insulin resistance ([@B1]), even though insulin clearance is not altered by acute hyperglycemia ([@B12]). The reduction in insulin clearance enhances glucose uptake and suppress lipolysis by increasing insulin levels. Consequently, it has been hypothesized that insulin clearance is reduced in insulin-resistant states to lessen the demands on the β-cell ([@B1]).

In an animal model of alloxan-induced selective decrease in β-cell mass, insulin secretion decreases in proportion to β-cell mass ([@B13]). Insulin secretion after meal ingestion is impaired along with worsening of hepatic insulin clearance. Human studies have also shown that skeletal muscle contributes to peripheral insulin clearance ([@B14],[@B15]). Physiological hyperinsulinemia recruits skeletal muscle capillaries, but insulin clearance is reduced because of the saturation of the trans endothelial insulin transport (a rate-limiting process for insulin action) ([@B14]). Obesity has been shown to impair microvascular recruitment ([@B15]). The cross-sectional nature of our study precludes us from making causal inferences. However, our results suggest that there is a complex relationship between insulin secretion and insulin clearance independently of the effect of obesity and insulin sensitivity.

This article contains Supplementary Data online at <http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-0101/-/DC1>.
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